• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

聚二甲基硅氧烷的仿生特性的体外表征及其对口服药物吸收的模拟

In Vitro Characterization of the Biomimetic Properties of Poly(dimethylsiloxane) To Simulate Oral Drug Absorption.

机构信息

Department of Physics, Grand Valley State University , Allendale, Michigan 49401, United States.

出版信息

Mol Pharm. 2017 Dec 4;14(12):4661-4674. doi: 10.1021/acs.molpharmaceut.7b00798. Epub 2017 Nov 20.

DOI:10.1021/acs.molpharmaceut.7b00798
PMID:29120190
Abstract

The potential use of poly(dimethylsiloxane) (PDMS) as an in vitro biomimetic analogue of the passive drug absorption process in the human gastrointestinal tract (GI) is assessed. PDMS is biomimetic because of similarities in small molecule transport, such as mechanism, ionization selectivity, lipophilicity. Nine molecular probes are used to evaluate the transport pathways and properties used to predict human oral absorption rates. The transport pathways through PDMS (bulk/pore) are analogous to transcellular (TCDT) and paracellular (PCDT) drug transport pathways. PDMS PCDT is assessed using positronium annihilation lifetime spectroscopy (PALS) and partition experiments; TCDT using diffusion and partition experiments. PALS determined that PDMS pores were uniform (D ∼ 0.85 nm), isolated, and void volume was unaffected by drug accumulation after equilibrium partitioning. Therefore, there is no PCDT or convective flow through PDMS. A strong linear correlation exists between predicted octanol-water partition coefficients and PDMS partition coefficients (LogK = 0.736 × LogP - 0.971, R = 0.981). The pH-partition hypothesis is confirmed in PDMS using ibuprofen over pH 2-12. Diffusivity through PDMS is a function of lipophilicity and polar surface area K × D = 4.46 × 10 × e(R = 0.963) and [Formula: see text] (R = 0.973). Varying the mass% of curing agent changed the lipophilicity and diffusivity (p < 0.02), but not practically (K × D = 2.23 × 10cms vs 2.60 × 10cms), and does affect elastic modulus (3.2% = 0.3 MPa to 25% = 3.2 MPa).

摘要

评估了聚二甲基硅氧烷(PDMS)作为人类胃肠道(GI)被动药物吸收过程体外仿生模拟物的潜在用途。PDMS 具有仿生特性,因为小分子运输的机制、离解选择性、亲脂性等方面存在相似性。使用九种分子探针来评估用于预测人体口服吸收率的运输途径和性质。PDMS 中的运输途径(本体/孔)类似于细胞间(TCDT)和细胞旁(PCDT)药物运输途径。使用正电子湮没寿命谱(PALS)和分配实验评估 PDMS 的 PCDT;使用扩散和分配实验评估 TCDT。PALS 确定 PDMS 孔是均匀的(D∼0.85nm)、孤立的,并且药物积累后平衡分配对空体积没有影响。因此,PDMS 中不存在 PCDT 或对流。预测的辛醇-水分配系数与 PDMS 分配系数之间存在很强的线性相关性(LogK=0.736×LogP-0.971,R=0.981)。在 PDMS 中,使用布洛芬在 pH 2-12 范围内证实了 pH-分配假说。PDMS 中的扩散系数是疏水性和亲水表面积的函数 K×D=4.46×10×e(R=0.963)和[Formula: see text](R=0.973)。改变固化剂的质量%会改变疏水性和扩散系数(p<0.02),但实际上不会(K×D=2.23×10cms 与 2.60×10cms),并且确实会影响弹性模量(3.2%=0.3MPa 至 25%=3.2MPa)。

相似文献

1
In Vitro Characterization of the Biomimetic Properties of Poly(dimethylsiloxane) To Simulate Oral Drug Absorption.聚二甲基硅氧烷的仿生特性的体外表征及其对口服药物吸收的模拟
Mol Pharm. 2017 Dec 4;14(12):4661-4674. doi: 10.1021/acs.molpharmaceut.7b00798. Epub 2017 Nov 20.
2
Ultrathin, Large-Area Membrane Diffusion Cell for pH-Dependent Simultaneous Dissolution and Absorption Studies.用于 pH 依赖性同时溶解和吸收研究的超薄、大面积膜扩散池。
Mol Pharm. 2020 Jul 6;17(7):2319-2328. doi: 10.1021/acs.molpharmaceut.0c00040. Epub 2020 Jun 16.
3
Surface chemical modification of poly(dimethylsiloxane)-based biomimetic materials: oil-repellent surfaces.聚二甲基硅氧烷基仿生材料的表面化学改性:拒油表面。
ACS Appl Mater Interfaces. 2009 Nov;1(11):2636-44. doi: 10.1021/am9004732.
4
Determination of polydimethylsiloxane-air partition coefficients using headspace sorptive extraction.采用顶空吸附萃取法测定聚二甲基硅氧烷-空气分配系数
J Chromatogr A. 2007 May 25;1150(1-2):183-9. doi: 10.1016/j.chroma.2006.10.062. Epub 2006 Nov 13.
5
Novel hydrophobicity ruler approach for determining the octanol/water partition coefficients of very hydrophobic compounds via their polymer/solvent solution distribution coefficients.通过聚合物/溶剂溶液分配系数测定极疏水化合物的正辛醇/水分配系数的新型疏水性标尺方法。
Anal Chem. 2005 Mar 1;77(5):1275-81. doi: 10.1021/ac048847r.
6
Stabilization of two-phase octanol/water flows inside poly(dimethylsiloxane) microchannels using polymer coatings.使用聚合物涂层稳定聚二甲基硅氧烷微通道内的两相辛醇/水流动。
Anal Bioanal Chem. 2006 Aug;385(8):1376-83. doi: 10.1007/s00216-006-0526-y. Epub 2006 Jun 14.
7
Dynamic permeation method to determine partition coefficients of highly hydrophobic chemicals between poly(dimethylsiloxane) and water.动态渗透法测定高疏水性化学品在聚二甲基硅氧烷和水之间的分配系数。
Anal Chem. 2007 Sep 1;79(17):6816-22. doi: 10.1021/ac0710073. Epub 2007 Aug 3.
8
Absorption of hydrophobic compounds into the poly(dimethylsiloxane) coating of solid-phase microextraction fibers: high partition coefficients and fluorescence microscopy images.疏水性化合物在固相微萃取纤维的聚二甲基硅氧烷涂层中的吸收:高分配系数和荧光显微镜图像。
Anal Chem. 2000 Feb 1;72(3):459-64. doi: 10.1021/ac990948f.
9
Quantitative analysis of molecular absorption into PDMS microfluidic channels.PDMS 微流道中分子吸收的定量分析。
Ann Biomed Eng. 2012 Sep;40(9):1862-73. doi: 10.1007/s10439-012-0562-z. Epub 2012 Apr 7.
10
Chemical and physical modifications to poly(dimethylsiloxane) surfaces affect adhesion of Caco-2 cells.化学和物理修饰聚二甲基硅氧烷表面会影响 Caco-2 细胞的黏附。
J Biomed Mater Res A. 2010 Jun 15;93(4):1260-71. doi: 10.1002/jbm.a.32621.

引用本文的文献

1
Microfluidic Systems to Mimic the Blood-Brain Barrier: from Market to Engineering Challenges and Perspectives.用于模拟血脑屏障的微流控系统:从市场到工程挑战与展望
ACS Biomater Sci Eng. 2025 Jun 25. doi: 10.1021/acsbiomaterials.4c02221.
2
Commercially Available Cell-Free Permeability Tests for Industrial Drug Development: Increased Sustainability through Reduction of In Vivo Studies.用于工业药物开发的市售无细胞渗透性测试:通过减少体内研究提高可持续性
Pharmaceutics. 2023 Feb 9;15(2):592. doi: 10.3390/pharmaceutics15020592.
3
Formulation predictive dissolution (fPD) testing to advance oral drug product development: An introduction to the US FDA funded '21st Century BA/BE' project.
制剂预测溶出度(fPD)测试以推进口服药物产品开发:美国 FDA 资助的“21 世纪生物等效性/生物利用度”项目介绍。
Int J Pharm. 2018 Sep 5;548(1):120-127. doi: 10.1016/j.ijpharm.2018.06.050. Epub 2018 Jun 23.